South Korea Epigenome Analysis Market 2023 by Company, Regions, Type and Application, Forecast to 2030

Report ID: IBI1724396 | Category: Service & Software | Pages: 130 | Format: PDF | Published Date: October 04,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3550.00 Multi User-$4550.00

Report Description
View Table of Contents

Report Summary

According to our (Infinity Business Insights) latest study, the South Korea Epigenome Analysis market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for South Korea Epigenome Analysis market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
South Korea Epigenome Analysis market size and forecasts, in consumption value ($ Million), 2019-2030
South Korea Epigenome Analysis market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
South Korea Epigenome Analysis market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
South Korea Epigenome Analysis market shares of main players, in revenue ($ Million), 2019-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of South Korea and key countries
To assess the growth potential for Epigenome Analysis
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the South Korea Epigenome Analysis market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, Merck, QIAGEN, F. Hoffmann-La Roche and Eisai, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Epigenome Analysis market is split by Type and by Application. For the period 2019-2030, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    DNA Methylation Analysis
    Analysis of DNA Interactions
    Chromatin Accessibility
    Conformation Assays
Market segment by Application
    Research Institutes
    Pharmaceutical Companies
    Biotechnology Companies
    Others
Market segment by players, this report covers
    Illumina
    Merck
    QIAGEN
    F. Hoffmann-La Roche
    Eisai
    Abcam
    Diagenode
    Active Motif
    Zymo Research Corporation
    Thermo Fisher Scientific
    Cellcentric
    Syndax
    New England Biolabs
    Epizyme
    Domainex
    Agilent Technologies
    AsisChem
    Enzo Life Sciences
    EpiGentek Group
    BioVision
    Promega Corporation
    GeneTex
    Pacific Biosciences of California
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Epigenome Analysis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Epigenome Analysis, with revenue, gross margin and South Korea market share of Epigenome Analysis from 2019 to 2023.
Chapter 3, the Epigenome Analysis competitive situation, revenue and South Korea market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2023.and Epigenome Analysis market forecast, by regions, type and application, with consumption value, from 2023 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Epigenome Analysis.
Chapter 13, to describe Epigenome Analysis research findings and conclusion.

1 Market Overview
    1.1 Product Overview and Scope of Epigenome Analysis
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Epigenome Analysis by Type
        1.3.1 Overview: South Korea Epigenome Analysis Market Size by Type: 2019 Versus 2022 Versus 2030
        1.3.2 South Korea Epigenome Analysis Consumption Value Market Share by Type in 2022
        1.3.3 DNA Methylation Analysis
        1.3.4 Analysis of DNA Interactions
        1.3.5 Chromatin Accessibility
        1.3.6 Conformation Assays
    1.4 South Korea Epigenome Analysis Market by Application
        1.4.1 Overview: South Korea Epigenome Analysis Market Size by Application: 2019 Versus 2022 Versus 2030
        1.4.2 Research Institutes
        1.4.3 Pharmaceutical Companies
        1.4.4 Biotechnology Companies
        1.4.5 Others
    1.5 South Korea Epigenome Analysis Market Size & Forecast
    1.6 South Korea Epigenome Analysis Market Size and Forecast by Region
        1.6.1 South Korea Epigenome Analysis Market Size by Region: 2019 VS 2022 VS 2030
        1.6.2 South Korea Epigenome Analysis Market Size by Region, (2019-2030)
        1.6.3 North America Epigenome Analysis Market Size and Prospect (2019-2030)
        1.6.4 Europe Epigenome Analysis Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Epigenome Analysis Market Size and Prospect (2019-2030)
        1.6.6 South America Epigenome Analysis Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Epigenome Analysis Market Size and Prospect (2019-2030)
2 Company Profiles
    2.1 Illumina
        2.1.1 Illumina Details
        2.1.2 Illumina Major Business
        2.1.3 Illumina Epigenome Analysis Product and Solutions
        2.1.4 Illumina Epigenome Analysis Revenue, Gross Margin and Market Share (2019-2023)
        2.1.5 Illumina Recent Developments and Future Plans
    2.2 Merck
        2.2.1 Merck Details
        2.2.2 Merck Major Business
        2.2.3 Merck Epigenome Analysis Product and Solutions
        2.2.4 Merck Epigenome Analysis Revenue, Gross Margin and Market Share (2019-2023)
        2.2.5 Merck Recent Developments and Future Plans
    2.3 QIAGEN
        2.3.1 QIAGEN Details
        2.3.2 QIAGEN Major Business
        2.3.3 QIAGEN Epigenome Analysis Product and Solutions
        2.3.4 QIAGEN Epigenome Analysis Revenue, Gross Margin and Market Share (2019-2023)
        2.3.5 QIAGEN Recent Developments and Future Plans
    2.4 F. Hoffmann-La Roche
        2.4.1 F. Hoffmann-La Roche Details
        2.4.2 F. Hoffmann-La Roche Major Business
        2.4.3 F. Hoffmann-La Roche Epigenome Analysis Product and Solutions
        2.4.4 F. Hoffmann-La Roche Epigenome Analysis Revenue, Gross Margin and Market Share (2019-2023)
        2.4.5 F. Hoffmann-La Roche Recent Developments and Future Plans
    2.5 Eisai
        2.5.1 Eisai Details
        2.5.2 Eisai Major Business
        2.5.3 Eisai Epigenome Analysis Product and Solutions
        2.5.4 Eisai Epigenome Analysis Revenue, Gross Margin and Market Share (2019-2023)
        2.5.5 Eisai Recent Developments and Future Plans
    2.6 Abcam
        2.6.1 Abcam Details
        2.6.2 Abcam Major Business
        2.6.3 Abcam Epigenome Analysis Product and Solutions
        2.6.4 Abcam Epigenome Analysis Revenue, Gross Margin and Market Share (2019-2023)
        2.6.5 Abcam Recent Developments and Future Plans
    2.7 Diagenode
        2.7.1 Diagenode Details
        2.7.2 Diagenode Major Business
        2.7.3 Diagenode Epigenome Analysis Product and Solutions
        2.7.4 Diagenode Epigenome Analysis Revenue, Gross Margin and Market Share (2019-2023)
        2.7.5 Diagenode Recent Developments and Future Plans
    2.8 Active Motif
        2.8.1 Active Motif Details
        2.8.2 Active Motif Major Business
        2.8.3 Active Motif Epigenome Analysis Product and Solutions
        2.8.4 Active Motif Epigenome Analysis Revenue, Gross Margin and Market Share (2019-2023)
        2.8.5 Active Motif Recent Developments and Future Plans
    2.9 Zymo Research Corporation
        2.9.1 Zymo Research Corporation Details
        2.9.2 Zymo Research Corporation Major Business
        2.9.3 Zymo Research Corporation Epigenome Analysis Product and Solutions
        2.9.4 Zymo Research Corporation Epigenome Analysis Revenue, Gross Margin and Market Share (2019-2023)
        2.9.5 Zymo Research Corporation Recent Developments and Future Plans
    2.10 Thermo Fisher Scientific 
        2.10.1 Thermo Fisher Scientific Details
        2.10.2 Thermo Fisher Scientific Major Business
        2.10.3 Thermo Fisher Scientific Epigenome Analysis Product and Solutions
        2.10.4 Thermo Fisher Scientific Epigenome Analysis Revenue, Gross Margin and Market Share (2019-2023)
        2.10.5 Thermo Fisher Scientific Recent Developments and Future Plans
    2.11 Cellcentric
        2.11.1 Cellcentric Details
        2.11.2 Cellcentric Major Business
        2.11.3 Cellcentric Epigenome Analysis Product and Solutions
        2.11.4 Cellcentric Epigenome Analysis Revenue, Gross Margin and Market Share (2019-2023)
        2.11.5 Cellcentric Recent Developments and Future Plans
    2.12 Syndax
        2.12.1 Syndax Details
        2.12.2 Syndax Major Business
        2.12.3 Syndax Epigenome Analysis Product and Solutions
        2.12.4 Syndax Epigenome Analysis Revenue, Gross Margin and Market Share (2019-2023)
        2.12.5 Syndax Recent Developments and Future Plans
    2.13 New England Biolabs
        2.13.1 New England Biolabs Details
        2.13.2 New England Biolabs Major Business
        2.13.3 New England Biolabs Epigenome Analysis Product and Solutions
        2.13.4 New England Biolabs Epigenome Analysis Revenue, Gross Margin and Market Share (2019-2023)
        2.13.5 New England Biolabs Recent Developments and Future Plans
    2.14 Epizyme
        2.14.1 Epizyme Details
        2.14.2 Epizyme Major Business
        2.14.3 Epizyme Epigenome Analysis Product and Solutions
        2.14.4 Epizyme Epigenome Analysis Revenue, Gross Margin and Market Share (2019-2023)
        2.14.5 Epizyme Recent Developments and Future Plans
    2.15 Domainex
        2.15.1 Domainex Details
        2.15.2 Domainex Major Business
        2.15.3 Domainex Epigenome Analysis Product and Solutions
        2.15.4 Domainex Epigenome Analysis Revenue, Gross Margin and Market Share (2019-2023)
        2.15.5 Domainex Recent Developments and Future Plans
    2.16 Agilent Technologies
        2.16.1 Agilent Technologies Details
        2.16.2 Agilent Technologies Major Business
        2.16.3 Agilent Technologies Epigenome Analysis Product and Solutions
        2.16.4 Agilent Technologies Epigenome Analysis Revenue, Gross Margin and Market Share (2019-2023)
        2.16.5 Agilent Technologies Recent Developments and Future Plans
    2.17 AsisChem
        2.17.1 AsisChem Details
        2.17.2 AsisChem Major Business
        2.17.3 AsisChem Epigenome Analysis Product and Solutions
        2.17.4 AsisChem Epigenome Analysis Revenue, Gross Margin and Market Share (2019-2023)
        2.17.5 AsisChem Recent Developments and Future Plans
    2.18 Enzo Life Sciences
        2.18.1 Enzo Life Sciences Details
        2.18.2 Enzo Life Sciences Major Business
        2.18.3 Enzo Life Sciences Epigenome Analysis Product and Solutions
        2.18.4 Enzo Life Sciences Epigenome Analysis Revenue, Gross Margin and Market Share (2019-2023)
        2.18.5 Enzo Life Sciences Recent Developments and Future Plans
    2.19 EpiGentek Group
        2.19.1 EpiGentek Group Details
        2.19.2 EpiGentek Group Major Business
        2.19.3 EpiGentek Group Epigenome Analysis Product and Solutions
        2.19.4 EpiGentek Group Epigenome Analysis Revenue, Gross Margin and Market Share (2019-2023)
        2.19.5 EpiGentek Group Recent Developments and Future Plans
    2.20 BioVision
        2.20.1 BioVision Details
        2.20.2 BioVision Major Business
        2.20.3 BioVision Epigenome Analysis Product and Solutions
        2.20.4 BioVision Epigenome Analysis Revenue, Gross Margin and Market Share (2019-2023)
        2.20.5 BioVision Recent Developments and Future Plans
    2.21 Promega Corporation
        2.21.1 Promega Corporation Details
        2.21.2 Promega Corporation Major Business
        2.21.3 Promega Corporation Epigenome Analysis Product and Solutions
        2.21.4 Promega Corporation Epigenome Analysis Revenue, Gross Margin and Market Share (2019-2023)
        2.21.5 Promega Corporation Recent Developments and Future Plans
    2.22 GeneTex
        2.22.1 GeneTex Details
        2.22.2 GeneTex Major Business
        2.22.3 GeneTex Epigenome Analysis Product and Solutions
        2.22.4 GeneTex Epigenome Analysis Revenue, Gross Margin and Market Share (2019-2023)
        2.22.5 GeneTex Recent Developments and Future Plans
    2.23 Pacific Biosciences of California
        2.23.1 Pacific Biosciences of California Details
        2.23.2 Pacific Biosciences of California Major Business
        2.23.3 Pacific Biosciences of California Epigenome Analysis Product and Solutions
        2.23.4 Pacific Biosciences of California Epigenome Analysis Revenue, Gross Margin and Market Share (2019-2023)
        2.23.5 Pacific Biosciences of California Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 South Korea Epigenome Analysis Revenue and Share by Players (2019-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Epigenome Analysis by Company Revenue
        3.2.2 Top 3 Epigenome Analysis Players Market Share in 2022
        3.2.3 Top 6 Epigenome Analysis Players Market Share in 2022
    3.3 Epigenome Analysis Market: Overall Company Footprint Analysis
        3.3.1 Epigenome Analysis Market: Region Footprint
        3.3.2 Epigenome Analysis Market: Company Product Type Footprint
        3.3.3 Epigenome Analysis Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
    4.1 South Korea Epigenome Analysis Consumption Value and Market Share by Type (2019-2023)
    4.2 South Korea Epigenome Analysis Market Forecast by Type (2023-2030)
5 Market Size Segment by Application
    5.1 South Korea Epigenome Analysis Consumption Value Market Share by Application (2019-2023)
    5.2 South Korea Epigenome Analysis Market Forecast by Application (2023-2030)
6 North America
    6.1 North America Epigenome Analysis Consumption Value by Type (2019-2030)
    6.2 North America Epigenome Analysis Consumption Value by Application (2019-2030)
    6.3 North America Epigenome Analysis Market Size by Country
        6.3.1 North America Epigenome Analysis Consumption Value by Country (2019-2030)
        6.3.2 United States Epigenome Analysis Market Size and Forecast (2019-2030)
        6.3.3 Canada Epigenome Analysis Market Size and Forecast (2019-2030)
        6.3.4 Mexico Epigenome Analysis Market Size and Forecast (2019-2030)
7 Europe
    7.1 Europe Epigenome Analysis Consumption Value by Type (2019-2030)
    7.2 Europe Epigenome Analysis Consumption Value by Application (2019-2030)
    7.3 Europe Epigenome Analysis Market Size by Country
        7.3.1 Europe Epigenome Analysis Consumption Value by Country (2019-2030)
        7.3.2 Germany Epigenome Analysis Market Size and Forecast (2019-2030)
        7.3.3 France Epigenome Analysis Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Epigenome Analysis Market Size and Forecast (2019-2030)
        7.3.5 Russia Epigenome Analysis Market Size and Forecast (2019-2030)
        7.3.6 Italy Epigenome Analysis Market Size and Forecast (2019-2030)
8 Asia-Pacific
    8.1 Asia-Pacific Epigenome Analysis Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Epigenome Analysis Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Epigenome Analysis Market Size by Region
        8.3.1 Asia-Pacific Epigenome Analysis Consumption Value by Region (2019-2030)
        8.3.2 China Epigenome Analysis Market Size and Forecast (2019-2030)
        8.3.3 Japan Epigenome Analysis Market Size and Forecast (2019-2030)
        8.3.4 South Korea Epigenome Analysis Market Size and Forecast (2019-2030)
        8.3.5 India Epigenome Analysis Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Epigenome Analysis Market Size and Forecast (2019-2030)
        8.3.7 Australia Epigenome Analysis Market Size and Forecast (2019-2030)
9 South America
    9.1 South America Epigenome Analysis Consumption Value by Type (2019-2030)
    9.2 South America Epigenome Analysis Consumption Value by Application (2019-2030)
    9.3 South America Epigenome Analysis Market Size by Country
        9.3.1 South America Epigenome Analysis Consumption Value by Country (2019-2030)
        9.3.2 Brazil Epigenome Analysis Market Size and Forecast (2019-2030)
        9.3.3 Argentina Epigenome Analysis Market Size and Forecast (2019-2030)
10 Middle East & Africa
    10.1 Middle East & Africa Epigenome Analysis Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Epigenome Analysis Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Epigenome Analysis Market Size by Country
        10.3.1 Middle East & Africa Epigenome Analysis Consumption Value by Country (2019-2030)
        10.3.2 Turkey Epigenome Analysis Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Epigenome Analysis Market Size and Forecast (2019-2030)
        10.3.4 UAE Epigenome Analysis Market Size and Forecast (2019-2030)
11 Market Dynamics
    11.1 Epigenome Analysis Market Drivers
    11.2 Epigenome Analysis Market Restraints
    11.3 Epigenome Analysis Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War
12 Upstream and Industry Chain
    12.1 Raw Material of Epigenome Analysis and Key Suppliers
    12.2 Manufacturing Costs Percentage of Epigenome Analysis
    12.3 Epigenome Analysis Production Process
    12.4 Industry Value Chain Analysis
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

South Korea Epigenome Analysis Market 2023 by Company, Regions, Type and Application, Forecast to 2030

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?